NASDAQ: DXCM - DexCom, Inc.

Yield per half year: -44.11%
Sector: Healthcare

Company Analysis DexCom, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (-8.52%) is higher than the sector average (-49.7%).
  • Current debt level 39.19% is below 100% and has decreased over 5 years from 65.7%.
  • The company's current efficiency (ROE=26.18%) is higher than the sector average (ROE=9.61%)

Disadvantages

  • Price (75.06 $) is higher than fair price (14.3 $)
  • Dividends (0%) are below the sector average (0.5496%).

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

DexCom, Inc. Healthcare Index
7 days 8.1% 2.5% 0.9%
90 days -34.5% -35.8% 8.5%
1 year -8.5% -49.7% 34.4%

DXCM vs Sector: DexCom, Inc. has outperformed the "Healthcare" sector by 41.18% over the past year.

DXCM vs Market: DexCom, Inc. has significantly underperformed the market by -42.87% over the past year.

Stable price: DXCM is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: DXCM with weekly volatility of -0.1638% over the past year.

3. Summary of the report

3.1. General

P/E: 96
P/S: 14.35

3.2. Revenue

EPS 1.27
ROE 26.18%
ROA 8.64%
ROIC 6.34%
Ebitda margin 25.31%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (75.06 $) is higher than the fair price (14.3 $).

Price is higher than fair: The current price (75.06 $) is 80.9% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (96) is higher than that of the sector as a whole (48.77).

P/E vs Market: The company's P/E (96) is higher than that of the market as a whole (48.12).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (25.13) is higher than that of the sector as a whole (4.82).

P/BV vs Market: The company's P/BV (25.13) is higher than that of the market as a whole (3.1).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (14.35) is lower than that of the sector as a whole (33.76).

P/S vs Market: The company's P/S indicator (14.35) is higher than that of the market as a whole (10.15).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (58.92) is higher than that of the sector as a whole (-22.12).

EV/Ebitda vs Market: The company's EV/Ebitda (58.92) is higher than that of the market as a whole (18.05).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 87.12% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (87.12%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.16%).

5.4. ROE

ROE vs Sector: The company's ROE (26.18%) is higher than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (26.18%) is higher than that of the market as a whole (10.88%).

5.5. ROA

ROA vs Sector: The company's ROA (8.64%) is higher than that of the sector as a whole (0.3359%).

ROA vs Market: The company's ROA (8.64%) is higher than that of the market as a whole (6.5%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (6.34%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (6.34%) is lower than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (39.19%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 65.7% to 39.19%.

Excess of debt: The debt is not covered by net income, percentage 453.43%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.5496%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (227.26%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Selling More insider purchases by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
09.09.2024 Leach Jacob Steven
EVP, Chief Operating Officer
Sale 69.15 51 586 746
09.09.2024 Sylvain Jereme M
EVP, Chief Financal Officer
Sale 69.15 51 586 746
09.09.2024 Stern Sadie
EVP, Chief HR Officer
Sale 69.15 29 458 426
30.08.2024 Brown Michael Jon
EVP, Chief Legal Officer
Sale 70 48 020 686
31.07.2024 Brown Michael Jon
EVP, Chief Legal Officer
Sale 69.55 45 347 652

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum DexCom, Inc.

9.3. Comments